(SOUTH SAN FRANCISCO, Calif.)Biotechnology company Exelixis Inc. said Monday its third-quarter loss nearly tripled from a year earlier, when it sold its plant traits business. Exelixis' net loss grew to $38.5 ...READ MORE

Among the earnings stories for Monday, Oct. 27, from AP Financial News: ST. LOUIS (AP)--Coal-producing Arch Coal Inc. said Monday its third-quarter earnings more than tripled, beat...READ MORE

(SOUTH SAN FRANCISCO)Biotechnology company Exelixis Inc. said Thursday it filed an investigational new drug application with the Food and Drug Administration for its cancer treatment candidate XL888.READ MORE

(SOUTH SAN FRANCISCO, Calif.)Biotechnology company Exelixis Inc. said Monday it could receive a $55 million payment if partner GlaxoSmithKline chooses to develop a potential cancer treatment.READ MORE

(NEW YORK)Shares of biotechnology company Exelixis Inc. rose Monday after the company said it started a late-stage study on its potential thyroid cancer drug. The stock rose 28 cents, or 4.6...READ MORE

Among the stock activity stories for Monday, July 21, from AP Financial News: NEW YORK (AP)--Shares of building products maker Gibraltar Industries Inc. soared Monday after a Piper...READ MORE

(SOUTH SAN FRANCISCO, Calif.)Biopharmaceutical company Exelixis on Friday said a six-year development agreement with GlaxoSmithKline PLC will expire as scheduled at the end of October.READ MORE